Last reviewed · How we verify
NCT06778343: BIRDD
Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
trial in Ankylosing Spondylitis in 134 participants. Currently enrolling.
31 March 2025
Quick facts
| Lead sponsor | Universidade Nova de Lisboa |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 134 |
| Start date | 31 January 2023 |
| Primary completion | 31 March 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Portugal |
Conditions studied
- Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →
- Rheumatic Arthritis — all drugs for Rheumatic Arthritis →
- Systemic Lupus Erythematosus — all drugs for Systemic Lupus Erythematosus →
Sponsor
Universidade Nova de Lisboa — full company profile →
Who can join
Adults 18 to 65, any sex, with Ankylosing Spondylitis or Rheumatic Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ankylosing spondylitis (AS), Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) are three diseases where early diagnosis remains a major challenge. However, early diagnosis is the main determinant for a better prognosis. In the early stage, symptoms may be nonspecific and often difficult to establish a differential diagnosis between rheumatic diseases and other diseases, namely infectious and cancer diseases.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06778343
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ankylosing Spondylitis
Currently open trials in the same condition.
- NCT07510789 — Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis · recruiting
- NCT07261644 — A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) · Phase 3 · recruiting
- NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
- NCT06905288 — Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. · recruiting
- NCT07166874 — The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis · NA · recruiting
Other Universidade Nova de Lisboa trials
Trials by the same sponsor.
- NCT05593835 — Multimorbidity Management Supported by a Digital Platform · NA · not yet recruiting
- NCT06794515 — cGMP: Metabolism and Appetite Modulation · NA · not yet recruiting
- NCT05788952 — The Role of Intestinal and Vaginal Microbiota, Estrogenic Activity, Metabolic Profile & Nutritional Status in Endometrio · unknown
- NCT05375487 — The Effect of Natural Carbonated Mineral Water Consumption on Gastrointestinal Transit and Gut Microbiota - A Randomized · NA · completed
- NCT05840627 — Acute Satiety and Metabolic Response of Daily Consumption of a Fruit Juice · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06778343 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Nova de Lisboa
- Last refreshed: 20 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06778343.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing